Literature DB >> 17962371

Idiopathic thrombocytopenic purpura and the second dose of MMR.

Julia Stowe, George Kafatos, Nick Andrews, Elizabeth Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17962371     DOI： 10.1136/adc.2007.126003

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  9 in total

1.  Do childhood vaccines cause thrombocytopenia?

Authors:  Laura J Sauvé; David Scheifele
Journal:  Paediatr Child Health       Date:  2009-01       Impact factor: 2.253

2.  Immunization rates at the school entry in 2012.

Authors:  Martin Weigel; Roswitha Bruns; Kerstin Weitmann; Wolfgang Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2014-11-14       Impact factor: 5.594

Review 3.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

4.  Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.

Authors:  Federica Bertuola; Carla Morando; Francesca Menniti-Ippolito; Roberto Da Cas; Annalisa Capuano; Giorgio Perilongo; Liviana Da Dalt
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 5.  Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.

Authors:  Lana Yh Lai; Faaizah Arshad; Carlos Areia; Thamir M Alshammari; Heba Alghoul; Paula Casajust; Xintong Li; Dalia Dawoud; Fredrik Nyberg; Nicole Pratt; George Hripcsak; Marc A Suchard; Dani Prieto-Alhambra; Patrick Ryan; Martijn J Schuemie
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

6.  Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination.

Authors:  Abdullah Algaissi; Edrous Alamer; Mohammed Jeraiby; Abeer Alomaish; Omer Elrhima; Sultan Qumayi; Naaif A Qasir; Halima Areeshi; Asma Masmali; Abdulaziz Alhazmi
Journal:  Saudi Med J       Date:  2022-06       Impact factor: 1.422

Review 7.  COVID-19 Vaccines and Autoimmune Hematologic Disorders.

Authors:  María Eva Mingot-Castellano; Nora Butta; Mariana Canaro; María Del Carmen Gómez Del Castillo Solano; Blanca Sánchez-González; Reyes Jiménez-Bárcenas; Cristina Pascual-Izquierdo; Gonzalo Caballero-Navarro; Laura Entrena Ureña; Tomás José González-López
Journal:  Vaccines (Basel)       Date:  2022-06-16

8.  SARS-CoV-2 vaccination in pediatric patients with immune thrombocytopenia.

Authors:  Kirsty Hillier; Jennifer A Rothman; Robert J Klaassen; Cindy Neunert; Melissa J Rose; Rachael F Grace; Michele P Lambert
Journal:  Pediatr Blood Cancer       Date:  2022-05-13       Impact factor: 3.838

9.  Exacerbation of immune thrombocytopenia following COVID-19 vaccination.

Authors:  David J Kuter
Journal:  Br J Haematol       Date:  2021-06-24       Impact factor: 8.615
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.